GV

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

Karim Faris

General Partner

Crystal Huang

Partner

Rick Klau

Partner

David Krane

Managing Partner

Daniel Lynch

Executive Venture Partner

David P. Schenkein

General Partner

KJ Sidberry

Principal

Krishna Yeshwant

General Partner

Sangeen Zeb

General Partner

960 past transactions

Comanche Biopharma

Venture Round in 2023
Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia.

AMP Robotics

Series C in 2023
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Cerevance

Series B in 2023
Cerevance LLC is engaged in the development of therapeutics targeting specific proteins expressed selectively in brain cell types affected by neurological diseases. The company utilizes its proprietary NETSseq platform to profile distinct brain cell types, such as neurons and glial cells, in mature human brain tissue. This technology reveals transcriptional and epigenetic differences, facilitating the early detection and treatment of serious neurological and psychiatric disorders, including Alzheimer’s and Parkinson’s diseases. Founded in 2016, Cerevance is headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom. The company's focus is on advancing new medicines for central nervous system diseases by addressing the underlying mechanisms of neurodegeneration and related conditions.

Moonhub

Seed Round in 2023
Moonhub's mission is to create economic opportunity for every person on the planet. They built the world's first AI Recruiter to find and hire the perfect person for every single job opening.

Jetpack

Seed Round in 2023
Jetpack creates scalable cloud backend software for engineers to help them with coding and cloud services. The platform develops software that builds scalable web backends for the cloud and creates images and configurations directly from annotated python code.

Flatfile

Series B in 2022
Flatfile Inc. offers a platform designed to streamline the data onboarding process for businesses by allowing developers to validate, map, and import data from various web applications. Founded in 2018 and based in Denver, Colorado, the company's key products include Portal, an import button that integrates seamlessly into software applications through a JavaScript snippet, and Concierge, which provides secure workspaces for collaboration on data ingestion challenges. Flatfile's platform supports multiple file formats, including CSV, XLS, and TSV, and features a JavaScript configurator that enables users to define target models for data validation. This automation helps organizations manage and structure imported data effectively, reducing the time spent on data cleaning and allowing teams to focus on utilizing their data for decision-making.

Sardine

Series B in 2022
FinTech, RegTech, Fraud Operating System

Pretzel Therapeutics

Series A in 2022
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Omni

Series A in 2022
Omni is the only BI platform that combines the consistency of a shared data model with the freedom of SQL. Omni was founded in 2022 and was headquartered in California, United States.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis

Series A in 2022
Xilis, Inc. develops next generation organoid technologies to guide precision therapy for cancer patients and improve drug discovery. It offers The XilisµO, a platform that enables rapid diagnostics, personalized drug screening, and scalable patient-derived models for high-throughput drug discovery. Xilis, Inc. was founded in 2019 and is based in Chapel Hill, North Carolina.

Merlin Labs

Series B in 2022
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.

MemSQL

Series F in 2022
MemSQL, now known as SingleStore, provides a real-time data warehouse solution that enables businesses to manage and operationalize diverse data across various platforms. The company focuses on facilitating faster adaptation to changing business needs and accelerating digital innovation by offering a unified platform for data management. SingleStore's services are available through major cloud providers such as AWS, Azure, and GCP, as well as through customized deployments. This flexibility allows organizations to run SingleStore's capabilities in environments that best suit their operational requirements.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

FYTO

Series A in 2022
FYTO provides innovative solutions which improve the economic and environmental sustainability of agriculture for farmers around the world. FYTO is developing: NOVEL NUTRIENT-DENSE CROPS that have ultra-high yields and ultra-low resource requirements, STATE-OF-THE ART CULTIVATION AND HARVESTING SYSTEMS for exceptional quality and consistency, CLIMATE-FRIENDLY METHODOLOGIES for resiliency and long-term sustainability, and a range of GROUNDBREAKING AGRICULTURAL PRODUCTS such as animal feed and biofertilizer.

Modular

Seed Round in 2022
Modular is an AI software developer platform that unifies the development and deployment of AI for everyone. The product breakthroughs will be powered by production quality infrastructure that brings together compilers and runtimes, is designed for heterogeneous computing, edge to datacenter distribution, and is focused on usability. Unifying software and hardware with a "just works" approach will save developers enormous time and increase their velocity.

Medallion

Series C in 2022
Medalion helps hospitals to empower their practice for market expansion while maintaining compliance.

Sanas

Series A in 2022
Sanas is a technology company that specializes in real-time accent translation services, aimed at reducing language barriers and facilitating clearer communication. Its innovative software allows users to speak in various accents without any noticeable lag, enabling better understanding among speakers. The solution is designed to be user-friendly, operating locally on devices, which gives individuals complete control over their accent-matching preferences. By providing the option to adjust accents during conversations, Sanas enhances communication experiences and promotes inclusivity in interactions.

Courier

Series B in 2022
Courier provides an API designed for developers to enhance user notification delivery by intelligently routing messages across various existing channels, such as email and messaging platforms. The API takes into account factors like user online status and previous engagement levels to determine the most effective communication method. Over the years, Courier has evolved significantly, continuously adapting to technological advancements to better serve its customers while maintaining stability in its management and operational approach. The company emphasizes the importance of customer success, fostering long-term relationships with its largest clients and collaborating closely to prepare for future developments in the industry.

Ahana

Series A in 2022
Ahana, founded in 2020 and located in San Mateo, California, specializes in PrestoDB-based ad hoc analytics solutions. As the first company to focus on bringing these offerings to market, Ahana aims to simplify ad hoc analytics for organizations of various sizes. The company's mission includes fostering growth and supporting the Presto community, which is already in extensive use by major internet companies. Ahana operates as a fully remote organization, reflecting its commitment to flexibility and modern workplace practices.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a New York-based company that provides a platform for booking medical appointments and consultations. Founded in 2018, the company aims to simplify healthcare by connecting patients directly with doctors, offering transparent pricing and clear descriptions of medical services. SesameCare primarily serves uninsured individuals or those who prefer to pay for their healthcare services upfront. By addressing the complexities and hidden costs often associated with traditional healthcare, Sesame seeks to make quality medical care more accessible and affordable for a broader range of patients.

Nava

Series B in 2022
Nava is a New York-based company that specializes in health insurance brokerage services aimed at delivering high-quality, affordable healthcare solutions to employers and their employees. The firm provides a range of healthcare tools, year-round employee advocacy, and continuous measurement to assess and recommend healthcare plans. By focusing on these aspects, Nava helps clients manage their employee benefits effectively while reducing overall plan costs. This approach allows businesses to offer the necessary benefits to their workforce, ensuring both accessibility and affordability in healthcare coverage.

Meltano

Seed Round in 2022
Meltano is an open-source DataOps platform that integrates various leading open-source tools for managing the data lifecycle. It incorporates the Singer standard for data integration, featuring a library of over 200 connectors, as well as tools like dbt for data transformation, Airflow for orchestration, and plans to include Superset for data visualization. Meltano aims to simplify the processes of configuration, deployment, and monitoring while allowing data teams to adopt practices such as version control and continuous integration/continuous deployment. The platform collaborates with a community of over 1,200 professionals from startups, global enterprises, and consultancies to advance data infrastructure. Thousands of active projects utilizing Meltano are presently in operation across various organizations, demonstrating its practical application and adaptability in the data management landscape.

Multiverse

Series D in 2022
Multiverse offers apprenticeship opportunities tailored for non-graduate individuals, positioning itself as an alternative to traditional university education. Founded in 2016 and based in London, the company focuses on providing career-oriented apprenticeships that empower young people to take charge of their professional journeys. By facilitating access to high-quality training and resources, Multiverse aims to create a fulfilling career path for its participants, moving away from conventional corporate training methods. The company also incorporates digital tools to help apprentices build their profiles and engage in social networking, enhancing their learning experience and career prospects.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, Inc. designs and manufactures sensors based device that maximizes the freshness of fresh produce throughout the supply chain. The company provides an ethylene-detection device that determines ripeness by calculating the ethylene gas produced by fruit and maximizes freshness and reduces spoilage of fruit. Strella Biotechnology, Inc. was founded in 2018 and is based in Philadelphia, Pennsylvania.

FarmWise

Series B in 2022
FarmWise Labs, Inc. specializes in the development and manufacturing of robotic machinery aimed at improving agricultural practices. The company focuses on creating vegetable weeders that offer effective weeding and thinning solutions, while also monitoring the growth of herbicides. Founded in 2016 and located in San Francisco, California, FarmWise employs mechanical engineering to enhance farming efficiency and streamline operations, ultimately supporting increased food production. The company was previously known as DeepLook, Inc.

Gametime

Venture Round in 2022
Gametime United, Inc. develops a mobile application to book tickets. The company’s application enables users to buy and sell tickets for NBA, NHL, MLB, MLS, NCAA, and NFL teams. It offers its application for iOS and Android platforms through App Store and the Google Play Store. The company was founded in 2012 and is based in San Francisco, California.

Motive

Series F in 2022
Motive, formerly known as KeepTruckin, Inc., is a San Francisco-based company that specializes in fleet management software and electronic logbook applications for mobile devices. Founded in 2013, Motive offers a comprehensive fleet management system designed for dispatchers, drivers, fleet managers, and owner-operators. Its solutions enable dispatchers and fleet managers to audit driver logs, track locations, and relay load information to drivers. The application allows drivers to send and record their driving logs, conduct vehicle inspections, and communicate with back-office personnel to enhance hours-of-service compliance and safeguard their CSA scores. Motive's electronic logging device (ELD) is recognized as one of the most user-friendly and affordable systems available. Trusted by over 400,000 drivers and 13,000 fleets, Motive aims to improve the efficiency and profitability of the trucking industry through innovative technology. The company has received backing from prominent investors, including Google Ventures and Index Ventures.

Mirvie

Series B in 2022
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.

Graft

Pre Seed Round in 2022
Graft is a cloud-native platform that uses AI techniques to unlock the value of text, images, video, audio, and graphs. There is no requirement for machine learning skills, no need to hire a team, and no infrastructure to build or maintain.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in developing protein-based therapeutics for animal health care. The company focuses on creating biopharmaceutical solutions that apply human biotechnology advancements to veterinary medicine. Invetx aims to build a premier innovation platform for veterinary therapeutics, collaborating with leading biotechnology firms, investors, and industry experts. Its team, which includes veterinary scientists and clinicians, is dedicated to discovering and developing a diverse portfolio of therapies and technologies. The company's vision is to enhance health outcomes for both pets and farm animals by leveraging biopharma technologies in the global animal health industry.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. is a private biotechnology company based in San Diego, California, focused on developing innovative therapies for neurological conditions, particularly Parkinson's disease. Established in 2018, the company utilizes induced pluripotent stem cells to create patient-specific restorative cell therapies. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version aimed at familial forms of the disease. Aspen Neuroscience combines genomic approaches with stem cell biology to advance its mission of modifying the course of Parkinson's disease through these novel therapeutic strategies.

deepset

Series A in 2022
We are building the next enterprise search engine fueled by NLP and open-source. Building on top of latest NLP research we leverage question answering & transfer learning to provide granular, semantic search results tailored to different domains.

OMass Therapeutics

Series B in 2022
OMass Technologies Ltd engages in drug discovery by applying mass spectrometry to the characterization of intact protein assemblies. The company offers biotherapeutics, membrane proteins, drug binding, and purifications guiding services. In addition, OMass Technologies Ltd offers structural mass spectrometry (MS) platforms, often referred to as native mass spectrometry, for characterizing complex protein assemblies. The company assists biotechnology and pharmaceutical companies in tackling drug targets and biotherapeutics. OMass Technologies Ltd was founded in 2016 and is based in Begbroke, United Kingdom.

Veza

Venture Round in 2022
Cookie.AI is a stealth-mode startup based in the Silicon Valley / Bay Area. We are building SaaS based security products in a dynamic and fast moving world of cybersecurity with ideas rooted in the era of privacy for the cloud. We are well-funded and backed by top-tier VCs and CEOs as angel investors. The founders are serial entrepreneurs who have experience in the full 0-to-1 journey with a successful exit with an acquisition. We are looking for founding engineers (summer interns also welcome!) with strong interests in security / cloud-native systems / identity / SaaS.

Waltz Health

Series A in 2022
Waltz Health operates in the pharmaceutical supply chain, focusing on creating innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company develops consumer tools aimed at guiding decisions related to prescription care, with a particular emphasis on the needs of both payers and consumers. By utilizing AI-driven marketplaces, Waltz Health seeks to reduce costs and enhance the decision-making process for users. Their offerings provide better pricing information and resources that empower consumers while assisting payers in managing their pharmacy benefits more effectively.

Rooser

Series A in 2022
Rooser connects seafood buyers and suppliers across Europe, providing them with the tools they need to trade efficiently, negotiate prices, and process deliveries. Rooser is located in Edinburgh, Scotland.

Gravity Sketch

Series A in 2022
Gravity Sketch Limited develops multi-platform three-dimensional (3D) creation tools and software solutions, including Gravity Sketch VR and Gravity Sketch iOS. Founded in 2014 and based in London, the company aims to enhance the efficiency of 3D product development for enterprise teams. Gravity Sketch VR enables users to create unique geometries, design 3D models, and produce artwork, while Gravity Sketch iOS provides a design application for iPad users. By focusing on customer needs, Gravity Sketch seeks to streamline workflows, improve collaboration among cross-functional teams, and expedite the creative process.

Viz

Series D in 2022
Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California, USA.

StackBlitz

Seed Round in 2022
StackBlitz is a developer of an integrated software used to offer comprehensive facilities to computer programmers for software development. Its software consists of a source code editor, build automation tools, and a debugger for creating sharing live projects that enable clients to get started with angular or react project without the need to deal with the installation of dependencies. The company also allows the developer to edit offline and tweak the application in real-time without page refresh and preserving the application state.

Rattle

Series A in 2022
Rattle is a technology company that offers a Salesforce integration solution aimed at enhancing the efficiency of sales and customer experience teams. By allowing users to access and manage Salesforce directly through Slack, Rattle addresses common challenges related to Salesforce adoption. This integration enables sales representatives to log calls, track essential metrics, and update opportunities seamlessly, facilitating real-time visibility into customer relationship management. The platform has proven effective for industry leaders, saving sales representatives an average of 30 minutes per day in pipeline management and reducing data hygiene issues by up to 50%. Rattle's solution ultimately allows marketing professionals to focus more on customer engagement rather than internal processes.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. is a technology company based in Newport Beach, California, specializing in cybersecurity solutions tailored for hybrid-cloud environments. Founded in 2017 by former members of renowned companies in the security sector, Obsidian Security focuses on leveraging artificial intelligence to address cyber threats. Its platform provides comprehensive services, including threat detection, breach remediation, and security hardening specifically for software as a service (SaaS) applications. The company's offerings aim to deliver intelligent identity protection and seamless security, enabling enterprises to safeguard their interconnected systems without hindering productivity. Backed by notable investors, Obsidian Security positions itself at the forefront of the evolving cybersecurity landscape.

Brightline

Series C in 2022
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, that focuses on the development and research of innovative drugs. Established in 2017, the company utilizes single-cell genomic analysis and machine learning to gain insights into the cellular ecosystems of diseases. This approach allows Celsius Therapeutics to identify critical biomarkers that can enhance patient care and contribute to the creation of transformative medicines. The company's commitment to advancing the understanding of complex diseases positions it as a key player in the biotechnology sector.

Digits

Series C in 2022
Digits Financial, Inc. develops software to provide real-time view into business’ finance. The company’s software facilitates processes related to financial reports and transaction records to eliminate manual work. It visualizes, understands, and manages business and handles interactions with accountants, investors, and advisors. The company was founded in 2018 and is based in San Francisco, California.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc., a biotechnology company, engages in the genomic discovery of new drug modalities from eukaryotic microbes. It utilizes an integrated genomically-enabled drug discovery platform to discover and develop a pipeline of new drugs from fungi. The company was incorporated in 2016 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.

Agolo

Series A in 2022
Agolo summarizes information faster and with broader coverage than any human. It also uses artificial intelligence to create summaries from your information in real-time. The company helps analysts act strategically instead of processing information. Agolo’s technology replicates the ingenuity of the human mind by analyzing content through the identification of various subjects and drawing connections between them. The company’s AI platform can analyze thousands of documents and produce a summary of the five key points, specific to the reader’s interests, in real-time. Agolo was founded in 2012 and is headquartered in New York, NY, USA.

Nothing

Series B in 2022
Nothing is removing the barriers between people and technology to create a seamless digital future.

DNAnexus

Series H in 2022
DNAnexus, Inc. specializes in cloud-based genome informatics and data management tools tailored for enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company provides a platform that facilitates the analysis of raw sequencing data, integrates genomic data with clinical information, and enhances collaboration among researchers. Key offerings include the MOSAIC Microbiome platform for microbiome research, DNAnexus Apollo for clinico-genomic data exploration, DNAnexus Titan for data analysis, and DNAnexus Portals, which create secure online workspaces for collaborative projects. Additionally, the Clinico-Genomic Data Solution aims to enhance disease-specific datasets through partnerships with healthcare providers, improving screening and treatment pathways for complex diseases. DNAnexus serves a diverse clientele, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

Bonnet

Venture Round in 2022
Bonnet Ltd., founded in 2019 and based in London, develops a charging-as-a-service platform that simplifies access to public electric vehicle chargers. The company aims to alleviate the inconvenience faced by drivers who must register for multiple charging networks. Bonnet offers a subscription service that enables users, both individuals and businesses, to utilize any public charger through a single account. The platform not only provides access to a comprehensive network of charging points across Europe but also features real-time charger availability information and contactless payment options. This approach enhances the user experience while promoting a more visible and accessible charging infrastructure for businesses.

dbt Labs

Series D in 2022
dbt Labs, founded in 2016 and based in Philadelphia, operates a software-as-a-service platform that specializes in open-source data engineering. The company's primary offering, the data build tool (dbt), empowers data analysts and engineers to organize, cleanse, and transform data for analysis using SQL. This platform facilitates data modeling, event tracking, and KPI measurement, enabling users to build efficient data transformation workflows. In addition to its core software, dbt Labs provides training and consulting services in data analytics, supporting organizations in leveraging their data more effectively. Through its mission to enhance the creation and dissemination of organizational knowledge, dbt Labs positions itself as a vital resource for businesses seeking to improve their data analytics capabilities.

Redpanda Data

Series B in 2022
Redpanda is a queue for people who deal with massive data streams.

Redpanda

Series B in 2022
Social Media Marketing Platform.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Helium

Series D in 2022
Helium Systems Inc. specializes in Internet of Things (IoT) solutions, focusing on the development of smart sensor devices for various industries. These sensors monitor critical environmental factors such as temperature, humidity, barometric pressure, motion, and light, aiding in facility management and quality control for medical products, energy efficiency, air quality, and refrigeration. The company offers a web and mobile dashboard that allows users to manage and access their sensor data easily. Additionally, Helium operates a peer-to-peer wireless network designed to enhance connectivity for low-power IoT devices. This network incentivizes individuals to act as network operators by rewarding them with cryptocurrency for verifying transactions and maintaining coverage through a unique algorithm called Proof-of-Coverage. Incorporated in 2013 and based in San Francisco, Helium continues to innovate in the IoT space, providing robust solutions for data transfer and network connectivity.

Overview

Series A in 2022
Overview.ai provides real time fault detection that uses cameras and AI to monitor manufacturing robots, shutting them down if something goes wrong. Its smart camera automatically learns normal machine routines to detect any deviations, crashes or anomalies. Its system catches misalignments, breakage, and out-of-sequence behavior before significant damage occurs to product or machine.

Genesis Global

Series C in 2022
GENESIS Global was originally started by a team of industry leaders in the Global Financial Markets space with extensive experience in front to back trading technologies across multiple asset classes and business lines. The members of their management and advisory team have held senior global management roles at investment banks around the world and at trading technology software vendors. Extensive experience with global financial technology vendors. They have a simple strategy, to be a global FinTech company providing best in class solutions and services which are in line with their client’s needs, goals and expectations. They have a disruptive framework technology and business model to achieve this strategy.

Homebound

Series C in 2022
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.

Neo.tax

Series A in 2022
Neo.tax is a tax preparation and filing service based in Mountain View, California, that specializes in assisting early-stage startups. The company offers a tax automation platform that employs machine learning algorithms to streamline the collection and organization of data from various sources, including emails, documents, project management tools, and financial systems. This technology generates comprehensive reports that detail all activities, expenses, and methodologies used to claim tax credits. By enhancing accuracy and simplifying the review process, Neo.tax aims to ensure that businesses are audit-ready, thereby facilitating a more efficient and reliable tax filing experience.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.

Scandit

Series D in 2022
Scandit AG, established in 2009 and headquartered in Zurich, Switzerland, specializes in mobile computer vision and augmented reality solutions, focusing on barcode scanning software. Its offerings include the Scandit Keyboard Wedge, which enables enterprise-grade barcode scanning on mobile devices, and the Barcode Scanner SDK, which allows for barcode scanning integration in web applications. The MatrixScan technology enhances the speed of barcode and text recognition, making it valuable for industries such as retail, logistics, manufacturing, healthcare, and government. Scandit's solutions are designed to improve operational efficiency by enabling mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating patient and medication tracking in healthcare settings. The company serves a diverse clientele, including well-known organizations like 7-Eleven, Carrefour, and Toyota, among others, and has additional offices in San Francisco, Boston, London, and Warsaw.

Seismic Therapeutic

Series A in 2022
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its IMPACT™ platform, Seismic Therapeutic aims to tackle key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This comprehensive approach facilitates the creation of optimized therapies that can reach patients more quickly. The company is developing a pipeline of innovative biologics targeting adaptive immune system dysregulation, with the goal of treating autoimmune diseases.

Lacework

Venture Round in 2022
Lacework, Inc. is a cloud security platform that specializes in automating security and compliance across various cloud environments, including AWS, Azure, GCP, and private clouds. The company's flagship solution, Polygraph, enhances cloud workload security by integrating with cloud providers' security measures to protect customer accounts, workloads, and data. It effectively identifies anomalies and offers actionable insights for incident remediation. Lacework's offerings include continuous compliance, workload security, container security, and support for applications and services in cloud environments, leveraging DevOps processes and automated tools. Established in 2014 and headquartered in Mountain View, California, Lacework aims to provide a comprehensive view of risks associated with cloud workloads and containers, facilitating a secure transition to cloud infrastructure.

Pecan

Series C in 2022
Pecan is an AI-based predictive analytics platform that streamlines the creation and deployment of predictive models for various business applications, including customer lifetime value, churn prediction, and market segmentation. Founded in 2016 and headquartered in Tel Aviv, Israel, Pecan eliminates the need for data preparation or engineering by directly connecting to raw data. The platform features a low-code interface and pre-built models that automate the predictive process, allowing organizations to generate and implement AI models within days, without requiring data science expertise. This comprehensive approach enables businesses to make informed decisions by predicting future outcomes and identifying actionable insights efficiently.

Synapticure

Seed Round in 2022
Synapticure is a tele neurology startup that provides tailored care to ALS (Amyotrophic Lateral Sclerosis) patients and their families.

TenSixteen Bio

Series A in 2022
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.

Censys

Series B in 2022
Censys, Inc. is a cybersecurity company specializing in internet scanning and asset identification solutions. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides an internet device search engine that allows users to discover and analyze devices connected to the Internet, including computers, servers, and smart devices. The platform is utilized for various applications such as attack surface management, monitoring remote workforces, and identifying potential threats. Censys is recognized for delivering real-time visibility and risk assessments, making it a valuable resource for researchers, corporations, and government entities. The company's data-driven security solutions are employed by notable organizations, including FireEye, Google, NATO, and the U.S. Department of Homeland Security, to enhance their cybersecurity measures and proactively address threats.

Leyden Labs

Series B in 2022
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.

Agtonomy

Seed Round in 2022
Agtonomy is a hybrid autonomy and tele-assist platform for agriculture vehicles.

Verana Health

Series E in 2022
Innovation in healthcare is hindered by the time and cost of bringing new products to market. Verana Health is partnering with medical associations to build a regulatory-grade data platform for health care innovation that utilizes specialty clinical data sets. Verana Health’s platform enables physicians and industry to work together towards their shared goal of accelerating the availability of better treatments and cures for patients. Learn more at veranahealth.com.

Lapse

Seed Round in 2021
Lapse is a social disposable camera app. The app lets close groups recreate the magic of old-school disposable cameras by taking 36 snaps to ‘rolls’ in private group chats.

Cockroach Labs

Series F in 2021
Cockroach Labs, Inc. specializes in the development of open-source database software, notably CockroachDB, a cloud-native, distributed SQL database designed for modern application development. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a robust solution that combines the functionality of SQL with the horizontal scalability typical of NoSQL systems. CockroachDB is engineered to support strongly-consistent ACID transactions and offers an SQL API for data management. Its architecture ensures minimal latency disruption and resilience against failures across various levels, including disk, machine, rack, and datacenter. Serving a diverse clientele from startups to Fortune 500 companies, Cockroach Labs enables organizations across multiple industries, including banking, retail, and media, to build applications that can scale efficiently and maintain operational continuity.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.

Dialpad

Series F in 2021
Dialpad, Inc. is a cloud-based communications platform that specializes in enterprise-level solutions for voice, video, messaging, and collaboration. Founded in 2011 and based in San Francisco, the company offers a suite of products, including Dialpad, Dialpad Sell, UberConference, and Dialpad Contact Center, all powered by VoiceAI technology. These tools provide features such as real-time transcription, automated note-taking, live sentiment analysis, and voice analytics, catering to the growing demand for effective remote communication. Dialpad's clients include notable organizations such as Motorola Solutions and Warby Parker. The company has formed strategic partnerships, including one with SoftBank Corp., and has attracted investments from various venture capital firms. Initially known as Switch Communications, Dialpad rebranded in 2016 to reflect its focus on modern business communication needs, enabling employees to collaborate securely from any device within a unified platform.

Synthesia

Series B in 2021
Synthesia Ltd. develops artificial intelligence driven video production platform to create high-end videos. The company’s video synthesis platform allows to create high-end videos for many applications, including personalized advertising, corporate communications, and e-learning. Its platform synchronizes the lip movements in a video to a new dialogue track, which enables video content to be translated into foreign languages, widening distribution channels. The company was incorporated in 2017 and is based in London, United Kingdom.

Wonder

Series A in 2021
Wonder is a gaming company focused on developing an all-in-one gaming platform specifically for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across different devices, thereby enhancing the overall gaming experience. Additionally, Wonder is exploring VR-ready gaming hardware to further enrich its offerings. Currently, the company operates in stealth mode, indicating that it is in the early stages of development and not yet publicly available.

Universe

Series B in 2021
Universe is a mobile-based website builder established in 2014 and headquartered in Brooklyn, New York. The platform aims to empower users to create customized websites quickly and easily, catering to the needs of small business owners and individuals who prefer mobile solutions. By offering a unique approach that eliminates complicated templates, Universe utilizes customizable website filters that allow users to arrange photos, videos, and icons on a grid pattern through a simple drag-and-drop interface. This enables users to build mobile-optimized websites in just minutes using the company's iOS app, providing them with full control over their online presence.

Quartet Health

Corporate Round in 2021
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Groundswell

Seed Round in 2021
Groundswell provides a SaaS platform for philanthropic giving, which enables companies to fund personal donor-advised funds for each employee. Employee users are also provided with tools such as tax-free investment opportunities, customized giving opportunities, frictionless donation options, and centralized impact reporting.

Upbound

Series B in 2021
Upbound, Inc. develops and offers a multi-cloud platform that enables organizations to treat multiple disparate cloud environments as one. The company's platform allows organizations to build scalable multi-cloud services. Its platform allows for automation, cost optimization, capacity overflow, failover, policy enforcement, and portability across cloud environments. The company was founded in 2017 and is based in Seattle, Washington.

Vercel

Series D in 2021
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.

mabl

Series C in 2021
Mabl Inc. offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. Founded in 2016 and based in Boston, Massachusetts, the company provides a scriptless testing solution as part of its software-as-a-service (SaaS) offerings. Mabl facilitates machine-driven regression testing and integrates seamlessly into the continuous integration and continuous delivery (CI/CD) development lifecycle. Its platform allows software development teams to create, execute, and maintain auto-healing tests efficiently, ensuring the rapid delivery of high-quality applications. Mabl serves a range of enterprise clients, including Johnson Controls, Liberty Mutual, Molina Healthcare, JetBlue, Dollar Shave Club, and Charles Schwab, who rely on its services for testing their critical applications.

Farmer Business Network

Series G in 2021
Farmer Business Network (FBN) is an independent agronomic information network designed to enhance the livelihoods of farmers by making data accessible and useful. Leveraging data science and machine learning, FBN offers its members unbiased insights about their fields, drawing on billions of data points collected from a vast network of farmers. The platform provides valuable resources such as product performance analytics, benchmarking, and predictive insights based on real-world agricultural data. By connecting farmers across the United States, FBN helps them achieve input savings, gain profitable insights, and secure better crop prices, ultimately fostering a collaborative environment that benefits the agricultural community.

Yellowbrick Data

Series C in 2021
Yellowbrick Data, Inc. specializes in developing and deploying data warehouse solutions, offering both on-premises and cloud-based services. Founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London, the company aims to simplify data warehousing for enterprises. Its products address the challenges of high availability, complex mixed workloads, and support for ad-hoc SQL queries, enabling massive scalability and accommodating large numbers of concurrent users. By providing powerful analytics capabilities in a hybrid cloud environment, Yellowbrick Data empowers organizations to make faster, data-driven decisions while ensuring cost-effectiveness.

Cambridge Epigenetix

Series D in 2021
Cambridge Epigenetix Limited, a bioscience company, provides epigenetic tools. It offers TrueMethyl oxidative bisulfite sequencing (oxBS-Seq), a technology that enables single-base resolution sequencing of hydroxymethyl cytosine (5hmC) and methylcytosine (5mC), as well as provides the analysis of the DNA methylome. The company’s products include TrueMethyl 6 and TrueMethyl 24 kits that enable quantitative measurement of 5hmC and 5mC, single-base resolution of methylation and hydroxymethylation analysis, and confirmation of the location of unmethylated cytosines. It offers its products through third party vendors, as well as online to business customers in the United Kingdom and internationally. Cambridge Epigenetix Limited was founded in 2012 and is based in Babraham, United Kingdom.

Antiva Biosciences

Series D in 2021
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.

Patina

Series A in 2021
We believe everyone should have the opportunity to live their best lives and age with dignity. That’s why we’re reinventing primary care with an approach designed to profoundly improve the healthcare and aging experience for older adults and their loved ones.

Modern Age

Series A in 2021
Modern Age is a health and wellness platform focused on improving the aging process for individuals. It offers health monitoring software that employs computer vision and machine learning to assess skin, hair, and bone health. The platform also integrates data collected from smart bands to create a comprehensive digital record of an individual's well-being. By analyzing this information, Modern Age provides personalized insights and treatment recommendations, empowering users to manage their health more effectively and lead healthier lives as they age.

Resistant AI

Series A in 2021
Resistant AI protects the machine learning system from adversarial manipulation and advanced fraud. We believe that responsible and systematic adoption of machine learning techniques can profoundly improve our lives. Our mission is to accompany our customers on this way and to ensure that the risks related to machine learning and AI adoption are responsibly detected, managed and resolved.

RightHand Robotics

Venture Round in 2021
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.

Sprinter Health

Series A in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Matter

Series A in 2021
Matter operates as a social reading app for articles, blogs, and newsletters. The company is based in the United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.